Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 86 for “"PDL1"”.

  1. Changing landscape of immuno-oncology: CAR-T therapy and PD1/PDL1 blockade

    … PD1 located on T cells, binds to PDL1 on cancer and stromal cells. This interaction induces exhaustion and anergy in infiltrating T cells, thereby prevent T cells from targeting cancer cells. As such, the newly approved checkpoint blockade antibodies, Nivolumab and Pembrolizumab, …

    bu Repository record for Changing landscape of immuno-oncology: CAR-T therapy and PD1/PDL1 blockade (opens in a new tab)

  2. PDL1-Expressing Macrophages as Drivers of Immune Suppression in Aggressive B-Cell Lymphoma

    … and clinical contexts, and to determine how PDL1-expressing macrophages contribute to immune suppression and tumor control. Systematic quantification of immune infiltrates across more than 260 cases of DLBCL, FL, MCL and CLL using multiplex immunofluorescence microscopy revealed marked …

    zurich

  3. Έκφραση PDL1 και συσχέτιση με κλινικο -παθολογοανατομικά χαρακτηριστικά ασθενών με μή μικροκυτταρικό καρκίνο πνεύμονα.

    Εισαγωγή Η ανοσοϊστοχημική έκφραση της πρωτεΐνης του συνδέτη του προγραμματισμένου κυτταρικού θανάτου 1 (PD-L1), αποτελεί προτεινόμενο – και αμφιλεγόμενο- δείκτη ανταπόκρισης στην ανοσοθεραπεία. Ο σκοπός της παρούσας μελέτης ήταν η περαιτέρω διερεύνηση της κλινικής της σημασίας σε ασθενείς με μη …

    athens Repository record for Έκφραση PDL1 και συσχέτιση με κλινικο -παθολογοανατομικά χαρακτηριστικά ασθενών με μή μικροκυτταρικό καρκίνο πνεύμονα. (opens in a new tab)

  4. DESIGNING ANTI-PDL1 ANTIBODY CONJUGATED POLYMERIC COACERVATES AS A NOVEL “NANO-IMMUNOTHERAPY” AGAINST HEPATOCELLULAR CARCINOMA

    … of immunogenic cell death and conjugated anti-PDL1 antibodies for immune checkpoint inhibition against murine hepatomas was thus designed. Several crucial insights have been gleaned which provide a roadmap for the improvement of future designs of nano-immunotherapies not only for a more robust …

    nus Repository record for DESIGNING ANTI-PDL1 ANTIBODY CONJUGATED POLYMERIC COACERVATES AS A NOVEL “NANO-IMMUNOTHERAPY” AGAINST HEPATOCELLULAR CARCINOMA (opens in a new tab) Download file for DESIGNING ANTI-PDL1 ANTIBODY CONJUGATED POLYMERIC COACERVATES AS A NOVEL “NANO-IMMUNOTHERAPY” AGAINST HEPATOCELLULAR CARCINOMA (opens in a new tab)

  5. Herstellung und Charakterisierung von anti-CD40- und anti-41BB-Fusionsproteinen mit PDL1-abhängiger agonistischer Aktivität

    … TNFR activation in tumor tissue, where a high PDL1 expression is frequent and therefore the formation of oligomeric transactivating (TNFSF3-TNFRSF3)2 complexes should only occur there by binding to PDL1-expressing cells. These receptor-ligand complexes are a prerequisite for the agonistic …

    wurz-thes Repository record for Herstellung und Charakterisierung von anti-CD40- und anti-41BB-Fusionsproteinen mit PDL1-abhängiger agonistischer Aktivität (opens in a new tab)

  6. B cell leukemia elicits a suppressive Tr1-CD4+ T cell response that can be reprogrammed with PDL1-blockade.

    … of BCR-ABL+ B-ALL, we showed that combining PDL1 checkpoint blockade with targeted therapy via the tyrosine kinase inhibitor nilotinib prevented leukemia relapse and improved survival. Depletion of CD4+ T cells abrogated the efficacy of the combination therapy, pointing to a key role for CD4s …

    umn Repository record for B cell leukemia elicits a suppressive Tr1-CD4+ T cell response that can be reprogrammed with PDL1-blockade. (opens in a new tab)

  7. Mελέτη μεθυλίωσης των γονιδίων RASSF1A, MLL3 και PDL1 σε κυκλοφορούντα καρκινικά κύτταρα ασθενών με πλακώδες καρκίνωμα Κεφαλής και Τραχήλου (HNSCC)

    … των υποκινητών των γονιδίων RASSF1A, MLL3 και PDL1 σε κυκλοφορούντα καρκινικά κύτταρα 53 ασθενών με HNSCC (συνολικός αριθμός δειγμάτων n=100) και 10 υγιών αιμοδοτών. Για την μεθυλίωση εφαρμόστηκε η τεχνική της μεθυλοεξαρτώμενης PCR σε πραγματικό χρόνο (Real-time MSP). Η απομόνωση όλων των …

    athens Repository record for Mελέτη μεθυλίωσης των γονιδίων RASSF1A, MLL3 και PDL1 σε κυκλοφορούντα καρκινικά κύτταρα ασθενών με πλακώδες καρκίνωμα Κεφαλής και Τραχήλου (HNSCC) (opens in a new tab)

  8. Προφίλ έκφρασης των SIGLEC1 και PDL1 στα κυκλοφορούντα μονοκύτταρα για την πρώιμη διαστρωμάτωση της ενεργοποίησης ιντερφερονών σε ιδιοπαθείς φλεγμονώδεις μυοπάθειες

    … MX1, ISG15, IFI6, GBP1, GBP2, PSMB8, SIGLEC1 και PDL1. Παράλληλα, τα ειδικά και σχετιζόμενα με τη μυοσίτιδα αυτοαντισώματα αξιολογήθηκαν με τη χρήση ανοσοαποτυπωτικών δοκιμασιών EUROLINE. Αποτελέσματα: Η επιφανειακή έκφραση του SIGLEC-1 ήταν σημαντικά αυξημένη σε όλους τους υποπληθυσμούς …

    athens Repository record for Προφίλ έκφρασης των SIGLEC1 και PDL1 στα κυκλοφορούντα μονοκύτταρα για την πρώιμη διαστρωμάτωση της ενεργοποίησης ιντερφερονών σε ιδιοπαθείς φλεγμονώδεις μυοπάθειες (opens in a new tab)

  9. Macrophage polarization and colorectal cancer immune checkpoint protein expression.

    … of cell surface immune checkpoint proteins (e.g. PDL1) to exert its effect. Most (>85%) of colorectal cancers do not express these proteins and this contributes in part to the poor prognosis and survival in patients with advanced disease. The patients in which immunotherapy is a potential …

    louisville Repository record for Macrophage polarization and colorectal cancer immune checkpoint protein expression. (opens in a new tab)

  10. Development of an MSC-based immune checkpoint inhibiting cell therapy

    … sPD1HAC outcompeted recombinant PD1 and anti-PDL1 monoclonal antibodies. It reduced PD1-PDL1 binding by 82-94 per cent at one-fifth the comparator concentration. Furthermore, a single intravenous dose of MSC.sPD1HAC significantly reduced pulmonary metastatic burden in C57BL/6 mice with B16.F10 …

    essex Download PDF for Development of an MSC-based immune checkpoint inhibiting cell therapy (opens in a new tab)

  11. Detection of genomic rearrangements in archival lymphoma tissues using targeted capture sequencing

    … CIITA and the programmed death 1 ligands PDL1 and PDL2 have been shown to contribute to an immune privilege phenotype in multiple B-cell lymphomas, with implications for novel therapeutic approaches. However, the landscape of fusion partners for these genes has not been well characterized …

    ubc Repository record for Detection of genomic rearrangements in archival lymphoma tissues using targeted capture sequencing (opens in a new tab) Download PDF for Detection of genomic rearrangements in archival lymphoma tissues using targeted capture sequencing (opens in a new tab)

  12. Impact of endosomal recycling inhibitors on drug resistant and immune tolerant breast cancers

    … by targeting the recycling of the glycoprotein PDL1, which is expressed on the surface of some tumour cells and binds to its cognate receptors on the surface of T cells. PDL1-PD1 binding leads to T cell inactivation. A number of ERIs were used to determine their impact on the levels of PDL1.

    cork Repository record for Impact of endosomal recycling inhibitors on drug resistant and immune tolerant breast cancers (opens in a new tab)

  13. Modulation of Immune Checkpoints by Tumour Extracellular Vesicles

    … association with drug resistance. In cell lines, PDL1, PDL2 and CD155 increased, while GAL9 and HVEM decreased with resistance. PDL1, PDL2 and GAL9 modulations were influenced by IFNγ and regulated by CCL2 and specific miRNAs. EVs carried IC and reflected the IC expression pattern of originating …

    the-open-u Download PDF for Modulation of Immune Checkpoints by Tumour Extracellular Vesicles (opens in a new tab)

  14. Bifunctional Fusion Protein PDL1sFv/MICAe for Cancer Immunothearpy

    … developed a novel bifunctional fusion protein, PDL1sFv/MICAe, which combines the tumor-targeting capability of an anti-PDL1 single-chain variable fragment (sFv) with the NK cells immunostimulatory properties of the MICA extracellular domain. In vitro functional assays revealed that PDL1sFv/MICAe …

    clemson Repository record for Bifunctional Fusion Protein PDL1sFv/MICAe for Cancer Immunothearpy (opens in a new tab)

  15. Comprehensive phenotypic characterization of functionally distinct monocyte subsets and their relationship to TB, HIV and TB/HIV co-infection

    … expression of Programmed cell death-ligand 1 (PDL1) on the three monocyte subsets. Like many of the other molecules we have addressed in this thesis, PDL1 expression was enhanced in participants with HIV, TB, and TB/HIV co-infection. Among participants with HIV, PDL1 was correlated with HIV-1 …

    qucosa-diss

  16. Ρυθμιστικά Τ-κύτταρα και επαγόμενη από απόπτωση φλεγμονή

    … FASL, TRAIL (apoptosis mediators)-PD1, PDL1, PDL2 and IL2, IFNG (markers of T-cell exhaustion and restoration)-TGF-B1,B2,B3, INHB-A,Β,C,Ε, ALK4, ALK5, SMAD2,3,4,7, CTGF (TGFB/Activins pathway).Protein expression of molecules with significant expression alterations were assessed by …

    greece Repository record for Ρυθμιστικά Τ-κύτταρα και επαγόμενη από απόπτωση φλεγμονή (opens in a new tab)

  17. Expresión génica de puntos de control inmunológicos y vías relacionadas en cáncer de mama: estudio clínico-patológico e in vitro en líneas celulares, mamosferas y co-cultivos

    … Los más estudiados han sido CTLA-4, PD1, PDL1 y PDL2. Sin embargo, en los últimos años se han descubierto nuevos miembros de la familia de proteínas B7 como B7-H2, B7-H3 (CD276), B7-H4, B7-H5, B7-H6 y B7-H7, las cuales pueden promover una respuesta coestimuladora o co-inhibidora, en …

    alicante Repository record for Expresión génica de puntos de control inmunológicos y vías relacionadas en cáncer de mama: estudio clínico-patológico e in vitro en líneas celulares, mamosferas y co-cultivos (opens in a new tab)

  18. Tumor Interferon Signaling Initiates And Sustains A Multigenic Resistance Program To Immune Checkpoint Blockade

    … that prolonged interferon signaling orchestrates PDL1-dependent and PDL1-independent resistance to immune checkpoint blockade (ICB), and to combinations such as radiation plus anti-CTLA4. Furthermore, we show that this interferon driven resistance mechanism primarily occurs in ICB resistant tumors …

    penn Repository record for Tumor Interferon Signaling Initiates And Sustains A Multigenic Resistance Program To Immune Checkpoint Blockade (opens in a new tab)

  19. Targeting Histone Deacetylases in Melanoma and T-cells to Improve Cancer Immunotherapy

    … For example, upregulation of the PD1 ligands PDL1 and PDL2 by tumor cells negatively regulates the anti-tumor functions of PD1-expressing infiltrating T-cells. Importantly, strategies targeting this inhibitory axis have shown outstanding clinical benefit for the treatment of solid and …

    usf Repository record for Targeting Histone Deacetylases in Melanoma and T-cells to Improve Cancer Immunotherapy (opens in a new tab)

Page 1 of 5